Literature DB >> 19492980

Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Jason R Thonhoff1, Luis Ojeda, Ping Wu.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by the selective loss of both spinal and upper motor neurons. One strategy in treating ALS is to use stem cells to replace lost spinal motor neurons. However, transplanted stem cell-derived motor neurons may not survive when exposed to the harsh microenvironment in the spinal cord of ALS. In particular, dysfunctional astrocytes and overactivated microglia in ALS may limit the survival of motor neurons generated from cell replacement therapy. On the other hand, stem cells may provide large quantities of motor neurons that can be used for studying glia-mediated toxic mechanisms and potential therapies in ALS. Here we will review methods and molecular factors for directed differentiation of stem cells into spinal motor neurons, the potential uses of these models for dissecting the mechanisms underlying glia-induced motor neuron degeneration and screening for new therapeutics aimed at protecting motor neurons in ALS, as well as discuss challenges facing the development of motor neuron replacement-based cell therapies for recovery in ALS.

Entities:  

Mesh:

Year:  2009        PMID: 19492980      PMCID: PMC2887342          DOI: 10.2174/157488809789057392

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  196 in total

1.  Determinants of rapid disease progression in ALS.

Authors:  Koji Yamanaka; Don W Cleveland
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

Review 2.  Neural crest stem and progenitor cells.

Authors:  Jennifer F Crane; Paul A Trainor
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 3.  Mechanisms of ventral patterning in the vertebrate nervous system.

Authors:  Giuseppe Lupo; William A Harris; Katharine E Lewis
Journal:  Nat Rev Neurosci       Date:  2006-02       Impact factor: 34.870

4.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Specification of motoneurons from human embryonic stem cells.

Authors:  Xue-Jun Li; Zhong-Wei Du; Ewa D Zarnowska; Matthew Pankratz; Lauren O Hansen; Robert A Pearce; Su-Chun Zhang
Journal:  Nat Biotechnol       Date:  2005-01-30       Impact factor: 54.908

6.  Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis).

Authors:  N Ende; F Weinstein; R Chen; M Ende
Journal:  Life Sci       Date:  2000-05-26       Impact factor: 5.037

7.  Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

Authors:  A Pramatarova; J Laganière; J Roussel; K Brisebois; G A Rouleau
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

8.  Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis.

Authors:  Chrissandra J Zagami; Philip M Beart; Nicole Wallis; Phillip Nagley; Ross D O'Shea
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452

9.  Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients.

Authors:  W A Pedersen; W Fu; J N Keller; W R Markesbery; S Appel; R G Smith; E Kasarskis; M P Mattson
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

Review 10.  Amyotrophic lateral sclerosis: recent advances and future therapies.

Authors:  Niranjanan Nirmalananthan; Linda Greensmith
Journal:  Curr Opin Neurol       Date:  2005-12       Impact factor: 5.710

View more
  17 in total

1.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

2.  Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.

Authors:  Iuliana Ristea Popescu; Charles Nicaise; Song Liu; Grégoire Bisch; Sarah Knippenberg; Valery Daubie; Delphine Bohl; Roland Pochet
Journal:  Stem Cells Transl Med       Date:  2013-02-14       Impact factor: 6.940

Review 3.  Stem cell technology for the study and treatment of motor neuron diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Thais Federici; Jonathan D Glass; Nicholas M Boulis; Eva L Feldman
Journal:  Regen Med       Date:  2011-03       Impact factor: 3.806

4.  Mutant SOD1 microglia-generated nitroxidative stress promotes toxicity to human fetal neural stem cell-derived motor neurons through direct damage and noxious interactions with astrocytes.

Authors:  Jason R Thonhoff; Junling Gao; Tiffany J Dunn; Luis Ojeda; Ping Wu
Journal:  Am J Stem Cells       Date:  2011-08-19

5.  Effect of intra-cisternal application of kainic acid on the spinal cord and locomotor activity in rats.

Authors:  Nilesh K Mitra; Tiffanie E W Goh; Thalisha Bala Krishnan; Vishna D Nadarajah; Arun K Vasavaraj; Tomoko Soga
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

6.  Clinical translation of stem cells in neurodegenerative disorders.

Authors:  Olle Lindvall; Roger A Barker; Oliver Brüstle; Ole Isacson; Clive N Svendsen
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

7.  Deep learning-based predictive identification of neural stem cell differentiation.

Authors:  Yanjing Zhu; Ruiqi Huang; Zhourui Wu; Simin Song; Liming Cheng; Rongrong Zhu
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

8.  Stem cells for spinal cord regeneration: Current status.

Authors:  Zain A Sobani; Syed A Quadri; S Ather Enam
Journal:  Surg Neurol Int       Date:  2010-12-25

9.  Critical role of PI3K/Akt/GSK3β in motoneuron specification from human neural stem cells in response to FGF2 and EGF.

Authors:  Luis Ojeda; Junling Gao; Kristopher G Hooten; Enyin Wang; Jason R Thonhoff; Tiffany J Dunn; Tianyan Gao; Ping Wu
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

10.  Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases.

Authors:  Katannya Kapeli; Gene W Yeo
Journal:  Front Neurosci       Date:  2012-10-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.